Clinical Study of Shanggan Granules in Treating Mild Influenza
- Conditions
- Influenza (mild)
- Registration Number
- ITMCTR2000003515
- Lead Sponsor
- Institute of Traditional Chinese Medicine and Clinical Medicine, China Academy of Chinese Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Those who meet the diagnostic criteria of clinically diagnosed cases and/or confirmed cases of Western medicine for influenza;
2. Those who meet the criteria of TCM syndrome differentiation for influenza (mild);
3. Acute respiratory tracts such as stuffy nose, runny nose, sore throat, cough, etc. Symptoms and/or accompanied by fever (formally measured axillary temperature of more than 5 minutes >= 37.5 degrees C, < 39.0 degrees C;
4. Age 14-70 years.
5. Course of disease <= 48 hours.
6. Previous physical fitness, no diseases other than influenza Diagnosis history and related medication history;
7. Voluntarily participating in this study and signing informed consent.
1. Patients diagnosed with tuberculosis, measles and AIDS combined with pneumocystis and other infectious diseases;
2. Those who are known to be allergic to the Chinese medicine ingredients or Western medicine used in this study;
3. Serious basic diseases such as heart, brain, lung, liver, kidney and blood system, such as patients with viral hepatitis, hemophilia, and psychosis;
4. patients with immunodeficiency or taking immunosuppressive agents or glucocorticoids within the past 3 months;
5. Before taking treatment, other internal medicines against the disease have been received, such as antiviral drugs, antibiotics, traditional Chinese medicine, etc.;
6. Those who have been vaccinated with influenza vaccine within 3 months before the consultation;
7. Pregnancy or puerperium women, unstable living environment, work place Patients who are likely to cause loss of follow-up due to frequent changes, or others who are unable or unwilling to cooperate;
8. Participate in other trials in the past 3 months.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TCM syndromes;Influenza A and B virus nucleic acid detection;
- Secondary Outcome Measures
Name Time Method